• / Free eNewsletters & Magazine
  • / My Account
Home>European Markets

European Markets

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Innovus Pharma Signs Exclusive License and Distribution Agreement with Luminarie in Australia, New Zealand and the Philippines for Zestra® for Female Sexual Arousal Disorder and Zestra Glide® for ...

    Innovus Pharma Signs Exclusive License and Distribution Agreement with Luminarie in Australia, New Zealand and the Philippines for Zestra® for Female Sexual Arousal Disorder and Zestra Glide® for Female Lubrication

  2. LONDON MARKETS: U.K. Stocks Rise For 2nd Day As Election Poll Weighs On Pound

    LONDON MARKETS: U.K. Stocks Rise For 2nd Day As Election Poll Weighs On Pound

  3. UPDATE: U.K. stocks rise for 2nd day as election poll weighs on pound

    UPDATE: U.K. stocks rise for 2nd day as election poll weighs on pound

  4. Welcome to the Jungle: Amazon's Australian Expedition to Rattle Retailers

    Welcome to the Jungle: Amazon's Australian Expedition to Rattle Retailers

  5. European Markets Creep Down Despite Macron Win; China Falls on Regulation Worries

    European Markets Creep Down Despite Macron Win; China Falls on Regulation Worries

  6. European Markets Creep Lower After Macron Victory

    European Markets Creep Lower After Macron Victory

  7. ASIA MARKETS: Japanese Stocks End Higher With Key Asian And European Markets Shut For Holiday

    ASIA MARKETS: Japanese Stocks End Higher With Key Asian And European Markets Shut For Holiday

  8. Japanese stocks end higher with key Asian and European markets shut for holiday

    Japanese stocks end higher with key Asian and European markets shut for holiday

  9. Germany's Schäuble: Greece Could Secure Bailout Deal in Late May

    Germany's Schäuble: Greece Could Secure Bailout Deal in Late May

  10. Germany's Schäuble: Greece Could Secure Bailout Deal in Late May -Update

    Germany's Schäuble: Greece Could Secure Bailout Deal in Late May -Update

12345

©2017 Morningstar Advisor. All right reserved.